Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.9405
-0.1295 (-12.10%)
At close: May 26, 2026, 4:00 PM EDT
0.9899
+0.0494 (5.25%)
After-hours: May 26, 2026, 4:19 PM EDT

RANI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3.171.631.03--2.72
Revenue Growth (YoY)
164.08%58.85%---488.10%
Gross Profit
3.171.631.03--2.72
Selling, General & Admin
19.0119.7423.9526.4826.8427.83
Research & Development
18.820.2126.6839.6236.6126.48
Other Operating Expenses
--3.71---
Total Operating Expenses
37.8139.9454.3466.163.4554.32
Operating Income
-34.64-38.31-53.31-66.1-63.45-51.6
Interest Income
1.020.831.763.31.250.09
Interest Expense
-2.04-2.89-5.03-5.09-1.07-0.47
Other Non-Operating Income (Expense)
-0.58-0.58----1.07
Total Non-Operating Income (Expense)
-1.02-2.64-3.27-1.780.18-1.45
Pretax Income
-36.23-40.95-56.58-67.88-63.34-53.09
Provision for Income Taxes
-----0.07-0.04
Net Income
-29.44-29.67-30.02-33.97-30.59-8.33
Minority Interest in Earnings
-6.79-11.28-26.57-33.91-32.76-44.76
Net Income to Common
-29.44-29.67-30.02-33.97-30.59-8.33
Shares Outstanding (Basic)
1036628262420
Shares Outstanding (Diluted)
1036628262420
Shares Change (YoY)
238.18%132.26%11.65%7.09%21.93%-58.34%
EPS (Basic)
-0.41-0.45-1.05-1.33-1.28-0.43
EPS (Diluted)
-0.41-0.45-1.05-1.33-1.28-0.43
Shares Outstanding
99.81121.5933.3126.0425.319.71
Free Cash Flow
--18.8-35.76-52.47-48.13-32.75
Free Cash Flow Per Share
--0.28-1.26-2.06-2.02-1.68
Gross Margin
100.00%100.00%100.00%--100.00%
Operating Margin
-1092.96%-2345.99%-5186.19%---1899.12%
Profit Margin
-1143.17%-2507.65%-5504.28%---1953.92%
FCF Margin
--1151.38%-3478.99%---1205.41%
EBITDA
-34.64-37.41-52.29-65.28-62.9-51.1
EBITDA Margin
-1092.96%-2290.88%-5086.19%---1880.82%
EBIT
-34.64-38.31-53.31-66.1-63.45-51.6
EBIT Margin
-1092.96%-2345.99%-5186.19%---1899.12%
Effective Tax Rate
-0.00%0.00%0.00%0.11%0.08%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q